Skip to main content
Tech.euFundingExplorerBeta

DCVC Bio

Investor profile

DCVC Bio has backed 3 European tech companies across 3 funding rounds between 2021 and 2025, joining rounds totalling €38M. Most active in Healthtech and Agritech. Data as of Nov 2026.

Deals
3
distinct rounds
Companies
3
backed
Active span
2021–2025
5 yrs
Total round €
€38M
sum of rounds joined

Deals by year

distinct rounds / year
DCVC Bio — deals by year — interactive chart.
Data table
DCVC Bio — deals by year
20211
20221
20251

Top sectors

by deals
DCVC Bio — top sectors — interactive chart.
Data table
DCVC Bio — top sectors
Healthtech2
Agritech1

Stages

by deals
DCVC Bio — stages — interactive chart.
Data table
DCVC Bio — stages
Seed1
Series A1
Other1

Countries

by deals
DCVC Bio — countries — interactive chart.
Data table
DCVC Bio — countries
UK2
Denmark1

Co-investment network

shared rounds
Co-investment network — interactive chart.
DCVC Bio — 3 dealsDCVC BioCapital — 1 shared deals · click to openCapitalJonathan Milner — 1 shared deals · click to openJonathan MilnerKhosla Ventures — 1 shared deals · click to openKhosla VenturesLightstone Ventures — 1 shared deals · click to openLightstone VenturesLilly — 1 shared deals · click to openLillyMagnetic Ventures — 1 shared deals · click to openMagnetic VenturesMark Stevenson — 1 shared deals · click to openMark StevensonOMERS Ventures — 1 shared deals · click to openOMERS VenturesOno Venture Investment (OVI) — 1 shared deals · click to openOno Venture Investment (OVI)Peer Schatz — 1 shared deals · click to openPeer SchatzRA Capital — 1 shared deals · click to openRA CapitalSV Health Investors — 1 shared deals · click to openSV Health Investors

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Relation TherapeuticsUK1€24M
BioPheroDenmark1€14M
Alchemab TherapeuticsUK1€0

Biggest deals

top 10 by amount
CompanyStageAmountDate
Relation TherapeuticsSeed€24M2022-06
BioPheroOther€14M2021-03
← Back to investors